Glaukos Corp. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
35.26 M |
Public Float |
27.53 M |
Glaukos Corp. | |
Stock Exchange | New York Stock Exchange |
EPS |
$0.33 |
Market Cap |
$2.84 B |
Shares Outstanding |
36.4 M |
Public Float |
34.05 M |
Address |
229 Avenida Fabricante San Clemente California 92672 United States |
Employees | - |
Website | http://www.glaukos.com |
Updated | 07/08/2019 |
Glaukos Corp. is an ophthalmic medical device company, which engages in the development and commercialization of surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Its Micro Invasive Glaucoma Surgery procedures are designed to reduce intraocular eye pressure by improving aqueous outflow through the natural physiologic pathway. The company was founded by Olav B. |